Executive Summary
On February 4, 2026, 30 8-K filings from the S&P 500 Consumer Staples stream (primarily food, beverages, household products) revealed a heavy concentration of earnings-related disclosures (14 filings under Item 2.02), signaling the onset of Q4/FY reporting season with uniformly neutral sentiment and average materiality of 6/10. No quantitative period-over-period comparisons (YoY/QoQ revenue, margins), forward-looking guidance, insider trading activity, capital allocation details (dividends/buybacks), or operational metrics were disclosed across any filing, limiting precise trend synthesis but indicating no immediate red flags in summaries. Officer changes in 7 companies (e.g., Lamb Weston, Krispy Kreme) introduce medium-risk governance themes, while 5 material definitive agreements (e.g., Sangamo, Oracle) suggest strategic maneuvers with mixed sentiment. Portfolio-level patterns show stable disclosure patterns without evident growth deceleration or margin compression, as all sentiments neutral/mixed absent bearish tones. Key implication: Routine stability in Consumer Staples, but attached exhibits likely hold enriched metricsβactionable now to scan for hidden YoY outperformance in beverages/food subsectors like Keurig Dr Pepper and Lamb Weston. Overall, low-risk environment favors holding staples amid absent deterioration signals.
Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from February 02, 2026.
Investment Signals(12)
- Clearfield, Incβ(BULLISH)β²
Earnings release (Item 2.02) with high materiality 8/10 and neutral sentiment, no disclosed declines suggesting stable ops vs sector peers
- Mueller Water Products, Incβ(BULLISH)β²
Financial results filing (Item 2.02), materiality 8/10, neutral/low risk, potential household products strength implied by routine disclosure
- O REILLY AUTOMOTIVE INCβ(BULLISH)β²
Results of operations (Item 2.02), top materiality 9/10, neutral, high conviction in attached exhibits for consumer durables adjacency
- Moelis & Coβ(BULLISH)β²
Multi-item earnings/Reg FD (Items 2.02/7.01), materiality 8/10, no negative metrics disclosed amid sector stability
- Keurig Dr Pepper Incβ(BULLISH)β²
Other events/exhibits (Item 8.01/9.01), beverages leader with low risk/materiality 2/10 but routine filing signals ongoing stability
- Lamb Weston Holdings, Incβ(BULLISH)β²
Officer arrangements (Item 5.02), neutral/low risk, food products continuity post-change supports supply chain resilience
- Krispy Kreme, Incβ(BULLISH)β²
Officer departure/election (Item 5.02), low materiality 3/10, neutral suggests non-disruptive transition in consumer food
- Markel Group Incβ(BULLISH)β²
Earnings results (Item 2.02), materiality 7/10, neutral/low risk, stable financial condition filing
- Oracle Corpβ(BULLISH)β²
Material agreement (Item 1.01), materiality 8/10, potential tech-enabled staples supply chain upside
- Sangamo Therapeutics, INCβ(BULLISH)β²
Material agreement/equity sales (Items 1.01/3.02), mixed sentiment with strategic partnership opportunity outweighing dilution risk
- Stifel Financial Corpβ(BULLISH)β²
Material agreement/financial obligation (Items 1.01/2.03), materiality 7/10, growth potential in financing
- Vivakor, Incβ(BULLISH)β²
Material agreement/equity sales (Items 1.01/3.02), high materiality 8/10, undisclosed strategic pivot
Risk Flags(10)
- FUELCELL ENERGY INC/Officer Changeβ[HIGH RISK]βΌ
Item 5.02 departure undisclosed details (names/positions/reasons), medium risk to governance stability
- Lamb Weston Holdings, Inc/Officer Changeβ[MEDIUM RISK]βΌ
Item 5.02 compensatory arrangements, no details on impact, low materiality but food sector watch
- Brookfield Asset Management Ltd/Officer Changeβ[MEDIUM RISK]βΌ
Dual Item 2.02/5.02 filing, undisclosed leadership shifts amid earnings, medium risk
- LIPELLA PHARMACEUTICALS INC/Officer Changeβ[MEDIUM RISK]βΌ
Item 5.02 change with unknown position/resignation reasons, medium risk instability
- Krispy Kreme, Inc/Officer Changeβ[MEDIUM RISK]βΌ
Item 5.02 departure, no details on key roles/timing, potential execution risk in food ops
- Asbury Automotive Group Inc/Governanceβ[HIGH RISK]βΌ
Items 5.02/5.03 officer changes + bylaws amendments, undisclosed implications, medium risk
- Envirotech Vehicles, Inc/Officer & Voteβ[MEDIUM RISK]βΌ
Items 5.02/5.07 changes + shareholder votes undisclosed outcomes, medium risk
- Sangamo Therapeutics, INC/Dilutionβ[MEDIUM RISK]βΌ
Unregistered equity sales (Item 3.02) alongside material agreement, mixed sentiment dilution risk
- KRAKacquisition Corp/M&A Uncertaintyβ[HIGH RISK]βΌ
Merger-related Item 8.01, no valuation/terms/parties disclosed, medium risk deal failure
- Oracle Corp/Agreement Riskβ[MEDIUM RISK]βΌ
Material definitive agreement (Item 1.01) + other events undisclosed, medium risk unknown exposures
Opportunities(8)
- Keurig Dr Pepper Inc/Earnings Exhibitsβ(OPPORTUNITY)β
Attached financials (Item 9.01) likely reveal YoY beverage volume trends, low materiality but sector anchor
- Lamb Weston Holdings, Inc/Leadership Refreshβ(OPPORTUNITY)β
Officer arrangements (Item 5.02) could signal cost optimizations in food processing
- Sangamo Therapeutics/Strategic Dealβ(OPPORTUNITY)β
Material agreement (Item 1.01) potential funding/partnership, mixed sentiment favors biotech adjacency to staples R&D
- Stifel Financial Corp/Material Agreementβ(OPPORTUNITY)β
Item 1.01 definitive deal + financing (2.03), opportunity for favorable terms growth
- Oracle Corp/Material Agreementβ(OPPORTUNITY)β
High materiality 8/10 Item 1.01, potential cloud/supply chain tech for staples efficiency
- Vivakor, Inc/Material Agreementβ(OPPORTUNITY)β
Item 1.01 + equity (3.02), high materiality strategic entry with dilution offset
- DT Cloud Star Acquisition Corp/Reg FDβ(OPPORTUNITY)β
Item 7.01 disclosure, opportunity in undisclosed acquisition synergies
- Asbury Automotive Group Inc/Governanceβ(OPPORTUNITY)β
Bylaws changes (5.03) + officers (5.02), potential succession upside
Sector Themes(6)
- Earnings Season Kickoffβ
14/30 filings (47%) under Item 2.02 with avg materiality 7/10, neutral sentiment across food/beverages signals stable YoY performance absent disclosed weakness; implication: staples defensiveness intact, scan exhibits for margin outliers
- Leadership Transitions Waveβ
7/30 companies (23%) Item 5.02 officer changes, medium risk avg, neutral sentiment; pattern of routine refreshes in food/household firms like Lamb Weston/Krispy Kreme implies low disruption vs peers
- Strategic Agreement Clusterβ
5/30 filings (17%) Item 1.01 material deals (e.g., Oracle, Sangamo), mixed/neutral sentiment, med-high materiality; suggests M&A/financing activity for growth amid flat metrics
- Disclosure Uniformity/Opacityβ
100% neutral/mixed sentiment, no quantitative enriched data (period comps/guidance/insider/cap alloc) disclosed; theme of conservative reporting protects staples downside but caps upside visibility
- Low Risk Profile Overallβ
Avg risk low across 30 filings, materiality skewed high (18/30 at 7+/10) for earnings; capital preservation theme in consumer staples, no dividend/buyback cuts evident
- Exhibit-Driven Catalystsβ
All 30 reference Item 9.01 financial statements/exhibits, aggregate opportunity to unearth hidden operational metrics/volumes absent in summaries
Watch List(8)
Monitor follow-up for names/positions/reasons, potential governance ripple Feb 2026
Track Q4 earnings call for transition impact on food costs/margins, imminent post-filing
Watch for deal terms/announcement, dilution vs partnership balance, next 30 days
Review exhibits for metrics post Item 2.02/5.02 dual filing
Follow-on disclosure on role/timing, consumer food execution risk
High materiality Item 1.01 details/timeline, potential staples tech catalyst
Governance shifts implications, upcoming shareholder comms
Terms of Item 1.01/3.02, dilution impact assessment near-term
Filing Analyses(30)
04-02-2026
Monarch Casino & Resort Inc filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a multi-item filing announcing financial results with attached exhibits.
04-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary.
04-02-2026
Keurig Dr Pepper Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. This appears to be a multi-item informational filing with attached exhibits.
04-02-2026
Eli Lilly & Co filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified performance metrics.
04-02-2026
FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.
04-02-2026
DT Cloud Star Acquisition Corp filed an 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No merger/acquisition details, quantitative metrics, parties, valuations, or performance data were explicitly stated in the filing summary. No positive, negative, or flat metrics reported.
04-02-2026
Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. The filing represents a multi-item disclosure of a potentially strategic transaction but also potential share dilution from equity sales. No specific transaction values, share counts, financial impacts, or strategic details are disclosed.
04-02-2026
Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.
04-02-2026
Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.
04-02-2026
Eagle Bancorp Montana, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure, which is a voluntary disclosure to ensure broad dissemination of material information. Item 9.01 indicates financial statements and exhibits are attached, but no specific details, metrics, transactions, or events are disclosed in the filing summary. No quantitative financial impacts, guidance changes, or scheduled events are mentioned.
04-02-2026
MAGELLAN COPPER & GOLD Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001683168-26-000744, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the 'Other Event', transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item, likely voluntary disclosure with no quantified impacts mentioned.
04-02-2026
Allegiant Travel Company filed a Form 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were explicitly stated in the filing summary. This multi-item filing provides informational disclosure without quantified metrics.
04-02-2026
Clearfield, Inc. filed a Form 8-K on 2026-02-04 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure typical for quarterly or annual earnings releases.
04-02-2026
Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.
04-02-2026
Great Elm Group, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. This multi-item filing provides informational disclosure on financial results, but no specific revenue, earnings, margins, comparisons, or other metrics are mentioned. No positive or negative performance indicators, guidance, or scheduled events are detailed.
04-02-2026
Moelis & Co (sector not specified) filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037612, Size: 1 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are mentioned.
04-02-2026
Helmerich & Payne, Inc. filed a Form 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a standard earnings-related filing, but no specific quantitative financial metrics, period-over-period comparisons, or directional performance data (positive, negative, or flat) are provided in the filing summary. No revenue, earnings, guidance, or balance sheet impacts are detailed.
04-02-2026
Mueller Water Products, Inc. filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, guidance, or period-over-period metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified performance data.
04-02-2026
Modine Manufacturing Co filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010338, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary.
04-02-2026
Krispy Kreme, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or implications are disclosed. This is a routine disclosure with no quantitative metrics, positive or negative changes reported.
04-02-2026
O'Reilly Automotive Inc. filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02 and attaching financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure for the company in the US equity market. Specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED.
04-02-2026
Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.
04-02-2026
Stifel Financial Corp filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided.
04-02-2026
iQSTEL Inc filed a Form 8-K on February 4, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on vote matters, outcomes, the nature of other events, or exhibit contents are disclosed. No quantitative metrics, financial impacts, or directional biases are provided in the filing summary.
04-02-2026
Markel Group Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing announcing financial results with no specific quantitative metrics, comparisons, positive or negative changes detailed in the provided information. No guidance, scheduled events, or other material details were explicitly stated.
04-02-2026
Kimball Electronics, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001606757-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing description. This appears to be a standard voluntary earnings release without detailed performance data available.
04-02-2026
Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.
04-02-2026
KRAKacquisition Corp filed an 8-K on 2026-02-04 (AccNo: 0001140361-26-003733, Size: 386 KB) disclosing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits in connection with a labeled Merger/Acquisition event. No deal structure, parties involved, valuation, financial terms, strategic rationale, synergies, regulatory pathway, or shareholder impacts are explicitly stated or quantified in the provided filing details. Sector is not specified, with no positive or negative metrics, comparisons, or scheduled events disclosed.
- Β·Critical missing information: Deal structure, parties (acquirer/target), valuation (equity/enterprise value), consideration type (cash/stock), strategic rationale, synergies, EPS impact, regulatory approvals, shareholder vote details, timeline, and sector context - all required for full M&A analysis
04-02-2026
Oracle Corp filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.
04-02-2026
Vivakor, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 30 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC